Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Enzyme-Linked Immunosorbent Assay (ELISA) market size will reach 2,023.44 Million USD in 2025 and is projected to reach 2,718.77 Million USD by 2032, with a CAGR of 4.31% (2025-2032). Notably, the China Enzyme-Linked Immunosorbent Assay (ELISA) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Enzyme-Linked Immunosorbent Assay (ELISA) is a highly sensitive laboratory technique used for detecting and quantifying the presence of specific antigens or antibodies in biological samples. It involves immobilizing the target molecule (antigen or antibody) onto a solid surface, such as a microplate, and then using a series of biochemical reactions, including enzyme-linked antibodies and color-changing substrates, to generate a measurable signal. The intensity of the signal is directly proportional to the amount of the target molecule in the sample, allowing for precise quantification. ELISA is widely used in medical diagnostics, research, and biotechnology for applications such as disease diagnosis, monitoring biomarkers, and antibody detection. Its versatility, accuracy, and adaptability to various targets have made ELISA a fundamental tool in scientific and clinical investigations.

The major global suppliers of Enzyme-Linked Immunosorbent Assay (ELISA) include Thermo Fisher Scientific, Enzo Life Sciences, BioLegend, Merck, Bio-Techne, BD Biosciences, Bio-Rad Laboratorie, Aviva Systems Biology, Repligen, Lifespan Biosciences, PerkinElmer, BioVision, Biomatik, Innovative Research, Shanghai Kehua Bio-Engineering, Biomerieux, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Enzyme-Linked Immunosorbent Assay (ELISA). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Enzyme-Linked Immunosorbent Assay (ELISA) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Enzyme-Linked Immunosorbent Assay (ELISA) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Enzyme-Linked Immunosorbent Assay (ELISA) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Enzyme-Linked Immunosorbent Assay (ELISA) Include:

Thermo Fisher Scientific

Enzo Life Sciences

BioLegend

Merck

Bio-Techne

BD Biosciences

Bio-Rad Laboratorie

Aviva Systems Biology

Repligen

Lifespan Biosciences

PerkinElmer

BioVision

Biomatik

Innovative Research

Shanghai Kehua Bio-Engineering

Biomerieux

Enzyme-Linked Immunosorbent Assay (ELISA) Product Segment Include:

Indirect ELISA

Sandwich ELISA

Competitive ELISA

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Product Application Include:

Laboratory

Testing Institutions

Hospital

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry PESTEL Analysis

Chapter 3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Porter's Five Forces Analysis

Chapter 4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Enzyme-Linked Immunosorbent Assay (ELISA) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources